BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36283326)

  • 61. Age, comorbidity, life expectancy, and pulmonary nodule follow-up in older veterans.
    Wong ML; Shi Y; Fung KZ; Ngo S; Elicker BM; Brown JK; Hiatt RA; Tang VL; Walter LC
    PLoS One; 2018; 13(7):e0200496. PubMed ID: 30044854
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Severe pulmonary hypertension associated with COPD: hemodynamic improvement with specific therapy.
    Girard A; Jouneau S; Chabanne C; Khouatra C; Lannes M; Traclet J; Turquier S; Delaval P; Cordier JF; Cottin V
    Respiration; 2015; 90(3):220-8. PubMed ID: 26277885
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A low resting heart rate at diagnosis predicts favourable long-term outcome in pulmonary arterial and chronic thromboembolic pulmonary hypertension. A prospective observational study.
    Hildenbrand FF; Fauchère I; Huber LC; Keusch S; Speich R; Ulrich S
    Respir Res; 2012 Sep; 13(1):76. PubMed ID: 22943191
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Late Onset Postcapillary Pulmonary Hypertension in Patients With Transposition of the Great Arteries and Mustard or Senning Baffles.
    Chaix MA; Dore A; Mercier LA; Mongeon FP; Marcotte F; Ibrahim R; Asgar AW; Shohoudi A; Labombarda F; Mondésert B; Poirier N; Khairy P
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025749
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The potential effect of cardiac function on pulmonary hypertension, other risk factors, and its impact on survival in dialysis patients.
    Rroji M; Cafka M; Seferi S; Seiti J; Barbullushi M; Goda A
    Int Urol Nephrol; 2021 Feb; 53(2):343-351. PubMed ID: 33389501
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-term effect of vasodilator therapy in pulmonary hypertension due to COPD: a retrospective analysis.
    Fossati L; Müller-Mottet S; Hasler E; Speich R; Bloch KE; Huber LC; Ulrich Somaini S
    Lung; 2014 Dec; 192(6):987-95. PubMed ID: 25348430
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
    Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of Pulmonary Hypertension on Survival Following Device Closure of Atrial Septal Defects.
    Ranard LS; Mallah WE; Awerbach JD; Abernethy A; Halane M; Qureshi AM; Krasuski RA
    Am J Cardiol; 2019 Nov; 124(9):1460-1464. PubMed ID: 31481180
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.
    Boucly A; Cottin V; Nunes H; Jaïs X; Tazi A; Prévôt G; Reynaud-Gaubert M; Dromer C; Viacroze C; Horeau-Langlard D; Pison C; Bergot E; Traclet J; Weatherald J; Simonneau G; Valeyre D; Montani D; Humbert M; Sitbon O; Savale L
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051269
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of pulmonary hypertension on long-term outcome in patients with severe aortic stenosis.
    Levy F; Bohbot Y; Sanhadji K; Rusinaru D; Ringle A; Delpierre Q; Smaali S; Gun M; Marechaux S; Tribouilloy C
    Eur Heart J Cardiovasc Imaging; 2018 May; 19(5):553-561. PubMed ID: 29106494
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ten-year Single Center Experience of Pulmonary Carcinoid Tumors and Diagnostic Yield of Bronchoscopic Biopsy.
    Dixon RK; Britt EJ; Netzer GA; Afshar M; Burke A; Liu S; Jean J; Shah NG
    Lung; 2016 Dec; 194(6):905-910. PubMed ID: 27544227
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Venous and Lung Thromboembolism in the Context of Lung Cancer: Clinical Manifestations, Risk Factors and Prognosis.
    Maia R; Neves I; Morais A; Queiroga H
    Acta Med Port; 2019 Oct; 32(10):647-653. PubMed ID: 31625877
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension: A Population-Based Cohort Study in Ontario, Canada.
    Wijeratne DT; Lajkosz K; Brogly SB; Lougheed MD; Jiang L; Housin A; Barber D; Johnson A; Doliszny KM; Archer SL
    Circ Cardiovasc Qual Outcomes; 2018 Feb; 11(2):e003973. PubMed ID: 29444925
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pulmonary hypertension is associated with higher mortality in cystic fibrosis patients awaiting lung transplantation.
    Venuta F; Tonelli AR; Anile M; Diso D; De Giacomo T; Ruberto F; Russo E; Rolla M; Quattrucci S; Rendina EA; Li Phd N; Coloni GF
    J Cardiovasc Surg (Torino); 2012 Dec; 53(6):817-20. PubMed ID: 23207567
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease.
    Savale L; Habibi A; Lionnet F; Maitre B; Cottin V; Jais X; Chaouat A; Artaud-Macari E; Canuet M; Prevot G; Chantalat-Auger C; Montani D; Sitbon O; Galacteros F; Simonneau G; Parent F; Bartolucci P; Humbert M
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31537700
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Incidence of Radiation Therapy Among Patients Enrolled in a Multidisciplinary Pulmonary Nodule and Lung Cancer Screening Clinic.
    Milligan MG; Lennes IT; Hawari S; Khandekar MJ; Colson Y; Shepard JO; Frank A; Sequist LV; Willers H; Keane FK
    JAMA Netw Open; 2022 Mar; 5(3):e224840. PubMed ID: 35357454
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.
    Montani D; Achouh L; Dorfmüller P; Le Pavec J; Sztrymf B; Tchérakian C; Rabiller A; Haque R; Sitbon O; Jaïs X; Dartevelle P; Maître S; Capron F; Musset D; Simonneau G; Humbert M
    Medicine (Baltimore); 2008 Jul; 87(4):220-233. PubMed ID: 18626305
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Exercise hypoxaemia as a predictor of pulmonary hypertension in COPD patients without severe resting hypoxaemia.
    Nakahara Y; Taniguchi H; Kimura T; Kondoh Y; Arizono S; Nishimura K; Sakamoto K; Ito S; Ando M; Hasegawa Y
    Respirology; 2017 Jan; 22(1):120-125. PubMed ID: 27471142
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pulmonary hypertension in bronchopulmonary dysplasia.
    Hansmann G; Sallmon H; Roehr CC; Kourembanas S; Austin ED; Koestenberger M;
    Pediatr Res; 2021 Feb; 89(3):446-455. PubMed ID: 32521539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.